2016 American Transplant Congress

Monday, June 13, 2016

6:00pm-7:00pm

Activating Transcription Factor 5 (ATF5) Regulates Liver Ischemia/Reperfusion Injury.

G.-Q. Shen,² M. Morita,¹ J. Fung,² L. Lu,^1,2 S. Qian.^1,2

Poster Session C: Ischemia Reperfusion Injury and Organ Preservation  •  Halls C&D

6:00pm-7:00pm

Activation of Innate Immunity During Human OLT-IRI Triggers Adaptive Immunity and Correlates with the Degree of IRI Injury.

A. Zarrinpar,¹ R. Sosa,² P. Rao,² C. Lassman,² R. Busuttil,¹ D. Gjertson,² J. Kupiec-Weglinski,¹ E. Reed.²

Poster Session C: Ischemia Reperfusion Injury and Organ Preservation  •  Halls C&D

6:00pm-7:00pm

Acute-on-Chronic Liver Failure Admissions Cost 3 Times More Than Non-ACLF Related Admissions.

S. Leffingwell, J. O'Leary, S. Asrani.

Poster Session C: Economics, Public Policy, Allocation, Ethics  •  Halls C&D

6:00pm-7:00pm

Adding Anti-Inflammatory Agents During Normothermic Ex-Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation.

N. Goldaracena, E. Juan, K. Moritz, V. Spetzler, A. Barbas, D. Grant, M. Selzner.

Poster Session C: Ischemia Reperfusion Injury and Organ Preservation  •  Halls C&D

6:00pm-7:00pm

Adenovirus Infection in Kidney Transplant Recipients: Report of a Case Series.

C. Simancas-Ruiz, L. Marino-Vazquez, A. Meraz-Muñoz, A. Nuñez-Abreu, R. Rivera-Marfil, N. Uribe-Uribe, J. Alberu, L. Morales-Buenrostro.

Poster Session C: Viruses and SOT  •  Halls C&D

6:00pm-7:00pm

After Alemtuzumab Induction, Tac+MMF Is Superior to CsA+MMF in Pediatric Kidney Transplantation.

M. Kaabak,¹ N. Babenko,¹ A. Zokoyev,¹ R. Shapiro.²

Poster Session C: Clinical Science - Kidney Immunosuppression: Induction Therapy  •  Halls C&D

6:00pm-7:00pm

Age Adapted Immunosuppression for Elderly Kidney Allograft Recipients: Balancing Risks for Cancer versus Rejection.

F. Jackson-Spence,¹ H. Gillott,¹ S. Tahir,¹ F. Evison,² J. Nath,³ A. Sharif.³

Poster Session C: Poster Session 1: Kidney Complications-Other  •  Halls C&D

6:00pm-7:00pm

Age and Education Level Are Predictors of Patient Preferences for Educational Formats in ESRD Patients Undergoing Transplant Education.

K. Leick,¹ J. Jones,¹ S. Witte,² L. Hunsicker,³ Z. Stewart.¹

Poster Session C: Economics, Public Policy, Allocation, Ethics  •  Halls C&D

6:00pm-7:00pm

Alemtuzumab Induction Allows Better Rejection Free Graft Survival in Comparison to Basiliximab Although with Increased Post Transplant Viral Infections.

V. Siddagangaiah,¹ H. Sharma,² N. Lal,¹ J. Rai,¹ M. Howse,¹ D. Ridgway,¹ A. Sharma,¹ A. Hammad,¹ S. Mehra.¹

Poster Session C: Clinical Science - Kidney Immunosuppression: Induction Therapy  •  Halls C&D

6:00pm-7:00pm

Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.

I. Yakubu,¹ B. Masters,¹ B. Ravichandran,¹ T. Sparkes,¹ M. Moss,¹ F. Rasetto,¹ S. Jonchhe,¹ B. Thomas,² N. Costa,² D. Leeser,² S. Bartlett,² A. Haririan.²

Poster Session C: Clinical Science - Kidney Immunosuppression: Induction Therapy  •  Halls C&D